Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
- 19 March 2019
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 45 (8), 1498-1504
- https://doi.org/10.1016/j.ejso.2019.03.020
Abstract
No abstract availableKeywords
Funding Information
- National Taiwan University Hospital (NTUH107-S3786)
- Ministry of Science and Technology (MOST105-2314-B-002-087)
- Ministry of Health and Welfare of Taiwan
This publication has 29 references indexed in Scilit:
- Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experienceCancer, 2017
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialThe Lancet Oncology, 2015
- The Global Burden of Cancer 2013JAMA Oncology, 2015
- Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter StudyAnnals of Surgical Oncology, 2015
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisThe Lancet Oncology, 2011
- A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal CancerAnnals of Surgery, 2010
- Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?The Journal of Thoracic and Cardiovascular Surgery, 2009
- Initial Stage Affects Survival Even After Complete Pathologic Remission is Achieved in Locally Advanced Esophageal Cancer: Analysis of 70 Patients With Pathologic Major Response After Preoperative ChemoradiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Pretreatment T3-4 Stage is an Adverse Prognostic Factor in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response Following Preoperative ChemoradiotherapyAnnals of Surgery, 2009
- Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved SurvivalJournal of Clinical Oncology, 2005